Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenretinide in Adult Cystic Fibrosis Patients
NCT02141958Phase 1Completed
- Start
- Apr 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in cystic fibrosis (CF) comparing Fenretinide with Placebo (2 arms). Primary endpoint: Assessment of the safety and tolerability of ascending doses of oral Fenretinide. Started Apr 2014; status: completed.
02
Drugs
fenretinide
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02141958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02141958.